Upgrade to SI Premium - Free Trial

HealthEquity (HQY) Tops Q2 EPS by 16c; offers guidance

September 3, 2024 4:03 PM

HealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.86, $0.16 better than the analyst estimate of $0.70. Revenue for the quarter came in at $299.9 million versus the consensus estimate of $285.13 million.

GUIDANCE:

HealthEquity sees FY2025 EPS of $2.98-$3.14, versus the consensus of $3.00. HealthEquity sees FY2025 revenue of $1.165-1.185 billion, versus the consensus of $1.171 billion.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

Categories

Earnings Guidance

Next Articles